Stay updated on IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.

Latest updates to the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check52 days agoChange DetectedThe study description has been updated to remove specific details about the patient population, changing from previously treated RAS-mutant tumors to a more general focus on advanced or metastatic solid tumors. Additionally, the date has been updated from February 19, 2025, to April 22, 2025.SummaryDifference1%
- Check60 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with 'Here’s how you know' in a different format.SummaryDifference1.0%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-19.SummaryDifference1.0%
Stay in the know with updates to IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-1-104 in RAS-Mutant Solid Tumors Clinical Trial page.